V. Janelle

发表

Early exposure to interleukin-21 limits rapidly generated anti-Epstein-Barr virus T-cell line differentiation.

J. Taillefer, D. Roy, Manon Richaud, 2015, Cytotherapy.

Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture

J. Taillefer, J. Delisle, C. Carli, 2015, Journal of Translational Medicine.

The strength of the T cell response against a surrogate tumor antigen induced by oncolytic VSV therapy does not correlate with tumor control.

P. Lapierre, L. Poliquin, V. Janelle, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Role of the complement system in NK cell-mediated antitumor T-cell responses

V. Janelle, A. Lamarre, 2014, Oncoimmunology.

How Informative is the Immune Response Against Surrogate Tumor Antigens to Assess Antitumor Immunity?

V. Janelle, A. Lamarre, 2014, Front. Oncol..

Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells

P. Lapierre, V. Janelle, A. Lamarre, 2015, Cellular and molecular gastroenterology and hepatology.

Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture

J. Taillefer, J. Delisle, C. Carli, 2015, Journal of Translational Medicine.

T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies

J. Delisle, V. Janelle, 2021, Cancers.

Advances in Cellular Immunotherapy: Understanding and Preventing T-cell Dysfunction

J. Delisle, V. Janelle, 2020 .

TGFβ Programs Central Memory Differentiation in Ex Vivo–Stimulated Human T Cells

J. Bramson, Manon Richaud, J. Delisle, 2019, Cancer Immunology Research.

Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity

S. Richards, R. Sékaly, M. Cameron, 2013, PLoS pathogens.

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies

J. Delisle, C. Carli, V. Janelle, 2020, Frontiers in Immunology.

p16INK4a Regulates Cellular Senescence in PD-1-Expressing Human T Cells

Frédérick A. Mallette, S. Lemieux, N. Labrecque, 2021, Frontiers in Immunology.

Transient Complement Inhibition Promotes a Tumor-Specific Immune Response through the Implication of Natural Killer Cells

P. Lapierre, L. Poliquin, V. Janelle, 2013, Cancer Immunology Research.

Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers

S. Lemieux, C. Perreault, P. Thibault, 2016, Leukemia.

The Bumpy Road to CAR Activation.

V. Janelle, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Mutations in the Glycoprotein of Vesicular Stomatitis Virus Affect Cytopathogenicity: Potential for Oncolytic Virotherapy

P. Lapierre, L. Poliquin, V. Janelle, 2011, Journal of Virology.

Combined PD-L1 and TIM-3 blockade improves the expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy

L. Busque, Vincent-Philippe Lavallée, A. Brasey, 2021, medRxiv.

Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy

Vincent-Philippe Lavallée, A. Brasey, J. Delisle, 2022, Molecular therapy. Methods & clinical development.

Multiparameter monitoring for optimal T-cell adoptive therapy.

J. Delisle, C. Carli, V. Janelle, 2015 .